CORRESP 3 filename3.htm Exhibit 2
 

Exhibit 2

CVF Technologies Corporation
SRE Controls
Working Trial Balance
March 31, 2004

SRE

SRE

Adj to minority position

Quarter Ended

03/31/04

Dr

CR

Adjusted

Dr

CR

Adjusted

Ownership %

37%

         

Balance

As of 3/25/04 (see attached)

Balance

ASSETS:
Cash

$

406,348

$

406,348

(406,348)

0

Accounts receivable

317,732

5)

(40,000)

277,732

(277,732)

0

Notes Receivable

3)

(1,751,000)

(1,751,000)

(1,751,000)

Inventories

633,350

633,350

(633,350)

0

Investment tax credits

43,600

5)

(15,781)

27,819

(27,819)

0

Prepaid expenses and deposits

53,325

53,325

(53,325)

0

Investments - equity & debt

1,723

6)

75,000

1)

(4,203,228)

(4,126,505)

(4,126,505)

Goodwill

1)

833,836

833,836

(833,836)

0

Accumulated amortization - goodwill

1)

(587,943)

(587,943)

587,943

0

Fixed assets - cost

427,610

427,610

(427,610)

0

Fixed assets - accum. Depr.

(355,836)

         

(355,836)

355,836

     

0

1,527,852

(4,161,264)

943,779

 

(2,660,020)

 

(5,877,505)

LIABILITIES AND EQUITY
Accounts payable trade

(1,194,683)

2)

(45,500)

(1,240,183)

1,240,183

0

Due to officers & other parties

0

Minority Interest

0

Notes payable

(680,000)

2)

(840,000)

(1,520,000)

1,520,000

0

Notes payable- CVF

0

3)

1,751,000

 2)

(1,751,000)

0

0

Interest payable - CVF

0

4)

46,090

55,402

(55,402)

0

1)

174,266

 2)

(164,954)

Bank Indebtedness

0

0

Preferred stock

0

0

Treasury

0

0

Common stock

0

0

Additional paid-in capital

(8,544,170)

1)

5,742,716

0

0

2)

2,801,454

Retained earnings

8,518,347

1)

4,206,681

1)

(6,166,328)

5)

86,081

6)

(75,000)

7)

473

5)

(30,300)

6,551,507

6,551,507

8)

7,015

9)

(9,211)

9)

13,749

Current year (Income) loss

372,654

 

9,211

 

(67,327)

 

314,538

95,510

 

(1,084,050)

 

(674,002)

$

(1,527,852)

 

15,747,572

 

(15,747,572)

$

4,161,264

2,855,693

(6,459,492)

5,877,505

CVF Technologies Corporation
SRE Controls
Working Trial Balance
March 31, 2004
Name of Entity

SRE

SRE

Adj to minority position  

Quarter Ended

03/31/04

Dr

CR

Adjusted

Dr

CR

Adjusted

Ownership %

37%

         

Balance

As of 3/25/04 (see attached)

Balance

REVENUES:
Sales

$

(607,799)

8)

(7,015)

$

(628,563)

95,510

(533,053)

9)

(13,749)

Leasing income

0

Rental income

0

Miscellaneous income

0

EXPENSES:
COGS

435,451

9)

9,211

444,662

(67,544)

377,118

Admin expenses

222,573

222,573

(17,383)

205,190

Advertising

0

Amortization - Goodwill

0

Amortization - Technology rights

0

Bad debts

0

0

Bank charges

3,302

3,302

(258)

3,044

Business taxes

0

Consulting

0

Commission expense (SH's)

0

Depreciation

9,000

9,000

(703)

8,297

Fianancing fees

0

Grants

0

Insurance

0

Interest expense

57,579

4)

(46,090)

11,489

(897)

10,592

Legal fees

0

Meals

0

Miscellaneous 7)

(473)

(473)

37

(436)

Lab supplies

0

Office lease - equipment

0

Office supplies

0

Provincial taxes

0

Relocation expense

0

Rent

0

Repairs & maintenance

0

Research & development

125,856

125,856

(9,829)

116,027

Sales and marketing

104,850

104,850

(8,189)

96,661

Telephone

0

Trade shows

0

Travel & Entertainment

0

Tax Credits

0

Utilities

0

Wages

0

Technology transfer

0

Foreign exchange (gain)

21,842

21,842

(1,706)

20,136

Loss on capital transactions

0

Minority Interest

0

CVF - gain on disposition

0

         

0

   

(977,578)

(977,578)

             

 

       
NET (INCOME) LOSS

$

372,654

 

9,211

 

(67,327)

$

314,538

95,510

(1,084,050)

(674,002)

0